Drug Profile
Influenza A virus H7N9 vaccines (Pandemic) - Protein Sciences Corporation
Alternative Names: Influenza A virus H7N9 vaccineLatest Information Update: 28 May 2021
Price :
$50
*
At a glance
- Originator Protein Sciences Corporation
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza A virus H7N9 subtype
Most Recent Events
- 28 May 2021 No recent reports of development identified for research development in Influenza-A virus H7N9 subtype(Prevention) in USA (Parenteral)
- 28 Aug 2017 Protein Sciences Corporation has been acquired by Sanofi
- 06 Apr 2017 Early research in Influenza-A virus H7N9 subtype (Prevention) in USA (Parenteral)